Company Name:Solid Biosciences Inc.
CEO: Ilan Ganot

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: Solid Biosciences Inc is a life science company engaged in developing therapies for Duchenne muscular dystrophy. Its product candidate, SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles.


Key numbers

Market Capitalization:161416476
Shares Outstanding: 45987600
Float: 30290974.4052
Next Earning Date:2019-11-19
TTm EPS: -2.9036
TTm Dividend Rate:
200 days moving average:8.5
50 days moving average: 10.29
One day percent Change: 9.35



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,